Regenerative Medicine and Tissue Engineering
Regenerative medicines and tissues engineering, are the branches of biomedical engineering. Tissue engineering and regenerative medicines are involved with the replacement or regeneration of cells, tissues or organs to revive traditional biological function. Tissue engineering could be a aggressive space of analysis that aims to make tissue equivalents of blood vessels, heart muscular tissue, nerves, cartilage, bone, and alternative organs for replacement of tissue either broken through sickness or trauma. As an knowledge domain field, principles from biological, chemical, electrical, materials science, and engineering are used in analysis and development.
The global Regenerative medicine market is expected to reach USD 38.70 Billion by 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6% from 2016 to 2021. The major factor driving the growth of this market, are government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.